Analyst price target range
MaxCyte Price Target: $4.11 Average
Direct answer
MaxCyte's average price target is $4.11.
The verified analyst range runs from $2.43 to $5.00.
The low target implies +104.2%, the high target implies +320.2%, and the range spans 216% of the current price.
Forecast evidence checked November 16, 2026.
Get free MaxCyte email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.19
- Average price target
- $4.11
- High price target
- $5.00
- Low price target
- $2.43
- Low target gap
- +104.2%
- Target upside
- +245.2%
- High target gap
- +320.2%
- Target range width
- 216%
- Consensus rating
- Strong Buy
- Analysts
- 4
- Evidence date
- November 16, 2026
- Valid through
- November 23, 2026
Explore related company data
Read the frequently asked questions.
What is MaxCyte's average price target?
MaxCyte's verified average price target is $4.11. The target range is $2.43 to $5.00.
How far are MaxCyte's low and high targets from the recorded price?
The low target implies +104.2%, while the high target implies +320.2%.
How many analysts are included in MaxCyte's consensus?
The verified consensus includes 4 analysts.
How is MaxCyte's target upside or downside calculated?
The average target of $4.11 is divided by the recorded price of $1.19, then one is subtracted to produce +245.2%. This does not guarantee a future return.
When was MaxCyte's analyst forecast verified?
The data was verified on 2026-11-16. The dataset is valid through 2026-11-23.